Literature DB >> 11259092

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas.

F Fina1, S Romain, L Ouafik, J Palmari, F Ben Ayed, S Benharkat, P Bonnier, F Spyratos, J A Foekens, C Rose, M Buisson, H Gérard, M O Reymond, J M Seigneurin, P M Martin.   

Abstract

Since the few data exploring a possible association between Epstein-Barr virus (EBV) and breast cancer are conflicting, we investigated this association together with the influences of geographical areas. 509 breast cancers were sampled from areas with varying risks of nasopharynx carcinoma (NPC) such as North Africa (Algeria and Tunisia, high-risk area); southern France (Marseille, intermediate-risk area); and northern Europe (northern France, the Netherlands and Denmark; low-risk areas). Polymerase chain reaction (PCR) of a subregion of EBV BamHIC encoding the EBERs demonstrated that 31.8% of the tumours contained the viral genome. No significant differences were observed among the geographical areas. However, positive samples showed higher loads of the EBV genome in the NPC high- and intermediate-risk areas than in the low-risk areas. EBV type 1 was the dominant strain. In situ hybridization studies using a(35)S-labelled riboprobe for EBER1 and a laser capture microdissection, combined with quantitative PCR, showed that EBV localization was restricted to some tumour epithelial cell clusters. EBV could not be detected in the stroma. Considering the whole population covered, the presence of the EBV genome was not correlated with age, menopausal status, tumour, size, nodal status or histological grade. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259092      PMCID: PMC2363823          DOI: 10.1054/bjoc.2000.1672

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Re: detection of Epstein-Barr virus in invasive breast cancers.

Authors:  A A Brink; A J van Den Brule; P van Diest; C J Meijer
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

2.  Detection of Epstein-Barr virus in invasive breast cancers.

Authors:  M Bonnet; J M Guinebretiere; E Kremmer; V Grunewald; E Benhamou; G Contesso; I Joab
Journal:  J Natl Cancer Inst       Date:  1999-08-18       Impact factor: 13.506

3.  Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia.

Authors:  F Tabbane; L Muenz; M Jaziri; M Cammoun; S Belhassen; N Mourali
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

4.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers.

Authors:  S L Glaser; R F Ambinder; J A DiGiuseppe; P L Horn-Ross; J L Hsu
Journal:  Int J Cancer       Date:  1998-02-09       Impact factor: 7.396

6.  Organisation of the Danish adjuvant trials in breast cancer.

Authors:  K W Andersen; H T Mouridsen; T Castberg; K Fischerman; J Andersen; K Hou-Jensen; H Brincker; H Johansen; E Henriksen; M Rørth; N Rossing
Journal:  Dan Med Bull       Date:  1981-08

Review 7.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2000-10       Impact factor: 5.098

8.  Breast cancer in women under 30 years of age.

Authors:  F Tabbane; A el May; M Hachiche; J Bahi; M Jaziri; M Cammoun; N Mourali
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Developmental regulation of peptidylglycine alpha-amidating monooxygenase (PAM) in rat heart atrium and ventricle. Tissue-specific changes in distribution of PAM activity, mRNA levels, and protein forms.

Authors:  L Ouafik; V May; H T Keutmann; B A Eipper
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

10.  Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.

Authors:  M Buisson; P Morand; O Genoulaz; M J Bourgeat; M Micoud; J M Seigneurin
Journal:  J Gen Virol       Date:  1994-02       Impact factor: 3.891

View more
  39 in total

1.  Absence of Epstein-Barr virus EBER transcripts in male breast cancer.

Authors:  Ricardo Fonseca; Ana Raquel Tomás; Saudade André
Journal:  Virchows Arch       Date:  2005-05-31       Impact factor: 4.064

2.  Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol).

Authors:  Hratch Arbach; Viktor Viglasky; Florence Lefeu; Jean-Marc Guinebretière; Vanessa Ramirez; Nadège Bride; Nadia Boualaga; Thomas Bauchet; Jean-Philippe Peyrat; Marie-Christine Mathieu; Samia Mourah; Marie-Pierre Podgorniak; Jean-Marie Seignerin; Kenzo Takada; Irène Joab
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women.

Authors:  Maryam Kadivar; Ahmad Monabati; Azadeh Joulaee; Niloufar Hosseini
Journal:  Pathol Oncol Res       Date:  2011-01-06       Impact factor: 3.201

4.  Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.

Authors:  Jiun-Han Lin; Ching-Hwa Tsai; Jan-Show Chu; Jeou-Yuan Chen; Kenzo Takada; Jin-Yuh Shew
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 5.  Role of the microbiome in non-gastrointestinal cancers.

Authors:  Meirav Pevsner-Fischer; Timur Tuganbaev; Mariska Meijer; Sheng-Hong Zhang; Zhi-Rong Zeng; Min-Hu Chen; Eran Elinav
Journal:  World J Clin Oncol       Date:  2016-04-10

6.  Outcome of Epstein-Barr virus-associated primary breast cancer.

Authors:  Chafika Mazouni; Frédéric Fina; Sylvie Romain; L'houcine Ouafik; Pascal Bonnier; Pierre-Marie Martin
Journal:  Mol Clin Oncol       Date:  2014-11-20

Review 7.  Epstein Barr virus-associated tumours: an update for the attention of the working pathologist.

Authors:  H-J Delecluse; R Feederle; B O'Sullivan; P Taniere
Journal:  J Clin Pathol       Date:  2007-09-14       Impact factor: 3.411

8.  Case report of concurrent primary malignancies of the breast and nasopharynx.

Authors:  Xinbin Pan; Xiaodong Zhu; Qingdi Quentin Li
Journal:  Oncol Lett       Date:  2012-05-15       Impact factor: 2.967

9.  Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.

Authors:  Deepti Joshi; Munira Quadri; Neha Gangane; Rajnish Joshi; Nitin Gangane
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

10.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.